Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

4.110 -0.160 (-3.75%)
Streaming Delayed Price Updated: 9:40 AM EDT, May 21, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 3,484
Open 4.270
Bid (Size) 4.100 (100)
Ask (Size) 4.230 (100)
Prev. Close 4.270
Today's Range 4.110 - 4.270
52wk Range 2.660 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
+30.1%
+30.1%
1 Month
-20.2%
-20.2%
3 Month
+20.5%
+20.5%
6 Month
+13.2%
+13.2%
1 Year
-2.1%
-2.1%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 4.110
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 05/21/26 09:40 AM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 8.57B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.